SCHEMBL8848474

SCHEMBL8848474

Cc1c(Cl)c2ccc(O)cc2oc1=O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B3 P37058 7/20 0.77
ESR1 P03372 5/20 0.61
ESR2 Q92731 5/20 0.61
PDE2A O00408 1/20 0.57
ERAP1 Q9NZ08 2/20 0.56
KDM4E B2RXH2 4/20 0.54
GLA P06280 4/20 0.54
GAA P10253 4/20 0.54
ALDH1A1 P00352 3/20 0.54
HPGD P15428 3/20 0.54
LMNA P02545 2/20 0.54
CASP1 P29466 2/20 0.54
CASP7 P55210 2/20 0.54
HSD17B10 Q99714 2/20 0.54
NPSR1 Q6W5P4 2/20 0.54
CA12 O43570 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2C9 P11712 1/20 0.54
AKR1B1 P15121 1/20 0.54
UGT1A1 P22309 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1024770 0.87 HSD17B3 (1.00) HSD17B3ESR1ESR2PDE2AERAP1
SCHEMBL10789179 0.87 HSD17B3 (0.62) HSD17B3ESR1ESR2PDE2AERAP1
SCHEMBL30640528 0.87 HSD17B3 (1.00) HSD17B3ESR1ESR2PDE2AERAP1
SCHEMBL31366988 0.86 HSD17B3 (1.00) HSD17B3ESR1ESR2PDE2AERAP1
SCHEMBL591899 0.86 HSD17B3 (1.00) HSD17B3ESR1ESR2PDE2AERAP1
SCHEMBL28446883 0.84 HSD17B3 (0.96) HSD17B3ESR1ESR2PDE2AERAP1
SCHEMBL10792486 0.84 HSD17B3 (0.73) HSD17B3ESR1ESR2PDE2AKDM4E
SCHEMBL31312649 0.83 HSD17B3 (0.80) HSD17B3ESR1ESR2PDE2AERAP1
SCHEMBL2321714 0.80 KDM4E (0.54) HSD17B3KDM4EGLAGAAALDH1A1
SCHEMBL10791460 0.80 HSD17B3 (0.75) HSD17B3ESR1ESR2PDE2AERAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0758361-A1 POLYMERISABLE COMPOSITON AND THE USE THEREOF Novartis AG (CH) 1997-02-19 EP disclosed
WO-1995029959-A1 POLYMERISABLE COMPOSITON AND THE USE THEREOF CIBA-GEIGY AG (CH) 1995-11-09 WO disclosed
EP-0111746-B1 SULFONIC-ACID ESTERS OF HYDROXYCOUMARINES, THEIR PREPARATION AND MEDICINES CONTAINING THEM BASF Aktiengesellschaft (DE) 1987-09-16 EP disclosed
US-4618622-A ANTIDEPRESSANTS, ANTIALLERGENS BASF AKTIENGESELLSCHAFT (DE) 1986-10-21 US disclosed
EP-0111746-A2 Sulfonic-acid esters of hydroxycoumarines, their preparation and medicines containing them BASF Aktiengesellschaft (DE) 1984-06-27 EP disclosed